What Is Best for Weight Loss? A Comparative Review of the Safety and Efficacy of Bariatric Surgery Versus Glucagon-Like Peptide-1 Analogue.

Klair, Nimra; Patel, Utkarsh; Saxena, Ayushi; Patel, Dhara; Ayesha, Ismat E; Monson, Neetha R; Ramphall, Shivana

Klair, Nimra; Patel, Utkarsh; Saxena, Ayushi; Patel, Dhara; Ayesha, Ismat E; Monson, Neetha R; Ramphall, Shivana.

Afiliación

Klair N; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Patel U; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Saxena A; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Patel D; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ayesha IE; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Monson NR; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ramphall S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus ; 15(9): e46197, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37905277

Palabras clave

bariatric surgery; glp-1 agonist; glucagon-like peptide-1 receptor agonist; obesity; overweight; ozempic; semaglutide; sleeve gastrectomy; wegovy; weight loss

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google